{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:01:57Z","timestamp":1791925317066,"version":"4.3.4"},"reference-count":159,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T00:00:00Z","timestamp":1575244800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T00:00:00Z","timestamp":1575244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s40265-019-01236-4","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T11:54:00Z","timestamp":1575287640000},"page":"9-21","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Management of Opioid-Tolerant Patients with Acute Pain: Approaching the Challenges"],"prefix":"10.1007","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1569-8056","authenticated-orcid":false,"given":"Pamela E.","family":"Macintyre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindy J.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine A.","family":"Huxtable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,2]]},"reference":[{"key":"1236_CR1","unstructured":"Schug SA, Palmer GM, Scott DA, Halliwell R, Trinca J, APM:SE Working Group of the Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine. Acute Pain Management Scientific Evidence. Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine, Melbourne. 2015. http:\/\/fpm.anzca.edu.au\/resources\/publications. Accessed 20 Jan 2017."},{"issue":"23","key":"1236_CR2","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1001\/jama.2018.18472","volume":"320","author":"JW Busse","year":"2018","unstructured":"Busse JW, Wang L, Kamaleldin M, Craigie S, Riva JJ, Montoya L, et al. Opioids for chronic noncancer pain: a systematic review and meta-analysis. JAMA. 2018;320(23):2448\u201360. https:\/\/doi.org\/10.1001\/jama.2018.18472.","journal-title":"JAMA"},{"issue":"5","key":"1236_CR3","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1213\/ANE.0000000000002500","volume":"125","author":"JC Ballantyne","year":"2017","unstructured":"Ballantyne JC. Opioids for the treatment of chronic pain: mistakes made, lessons learned, and future directions. Anesth Analg. 2017;125(5):1769\u201378. https:\/\/doi.org\/10.1213\/ANE.0000000000002500.","journal-title":"Anesth Analg"},{"key":"1236_CR4","doi-asserted-by":"publisher","first-page":"CD012299","DOI":"10.1002\/14651858.cd012299.pub2","volume":"10","author":"C Els","year":"2017","unstructured":"Els C, Jackson TD, Hagtvedt R, Kunyk D, Sonnenberg B, Lappi VG, et al. High-dose opioids for chronic non-cancer pain: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2017;10:CD012299. https:\/\/doi.org\/10.1002\/14651858.cd012299.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"1236_CR5","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/01.j.pain.0000460357.01998.f1","volume":"156","author":"KE Vowles","year":"2015","unstructured":"Vowles KE, McEntee ML, Julnes PS, Frohe T, Ney JP, van der Goes DN. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain. 2015;156(4):569\u201376. https:\/\/doi.org\/10.1097\/01.j.pain.0000460357.01998.f1.","journal-title":"Pain"},{"issue":"6","key":"1236_CR6","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1634\/theoncologist.2015-0012","volume":"20","author":"JH Kwon","year":"2015","unstructured":"Kwon JH, Tanco K, Park JC, Wong A, Seo L, Liu D, et al. Frequency, predictors, and medical record documentation of chemical coping among advanced cancer patients. Oncologist. 2015;20(6):692\u20137. https:\/\/doi.org\/10.1634\/theoncologist.2015-0012.","journal-title":"Oncologist."},{"issue":"3","key":"1236_CR7","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.psym.2018.01.003","volume":"59","author":"P Ho","year":"2018","unstructured":"Ho P, Rosenheck R. Substance Use disorder among current cancer patients: rates and correlates nationally in the department of veterans affairs. Psychosomatics. 2018;59(3):267\u201376. https:\/\/doi.org\/10.1016\/j.psym.2018.01.003.","journal-title":"Psychosomatics."},{"issue":"4","key":"1236_CR8","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1097\/j.pain.0000000000001459","volume":"160","author":"OM Fredheim","year":"2019","unstructured":"Fredheim OM, Skurtveit S, Handal M, Hjellvik V. A complete national cohort study of prescriptions of analgesics and benzodiazepines to cancer survivors in Norway 10\u00a0years after diagnosis. Pain. 2019;160(4):852\u20139. https:\/\/doi.org\/10.1097\/j.pain.0000000000001459.","journal-title":"Pain"},{"key":"1236_CR9","unstructured":"International Narcotics Control Board. Annual Report Highlights 2018. 2019. https:\/\/www.incb.org\/documents\/Publications\/AnnualReports\/AR2018\/LAUNCH\/Highlights.pdf. Accessed 27 July 2019"},{"key":"1236_CR10","unstructured":"OECD. Addressing problematic opioid use in OECD countries. 2019. https:\/\/read.oecd-ilibrary.org\/social-issues-migration-health\/addressing-problematic-opioid-use-in-oecd-countries_a18286f0-en#page1. Accessed 28 July 2019"},{"issue":"5","key":"1236_CR11","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/pds.4369","volume":"27","author":"EA Karanges","year":"2018","unstructured":"Karanges EA, Buckley NA, Brett J, Blanch B, Litchfield M, Degenhardt L, et al. Trends in opioid utilisation in Australia, 2006-2015: insights from multiple metrics. Pharmacoepidemiol Drug Saf. 2018;27(5):504\u201312. https:\/\/doi.org\/10.1002\/pds.4369.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"1236_CR12","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.bja.2018.02.022","volume":"120","author":"N Torrance","year":"2018","unstructured":"Torrance N, Mansoor R, Wang H, Gilbert S, Macfarlane GJ, Serpell M, et al. Association of opioid prescribing practices with chronic pain and benzodiazepine co-prescription: a primary care data linkage study. Br J Anaesth. 2018;120(6):1345\u201355. https:\/\/doi.org\/10.1016\/j.bja.2018.02.022.","journal-title":"Br J Anaesth"},{"key":"1236_CR13","unstructured":"Hedegaard H, Minino AM, Warner M. Drug Overdose Deaths in the United States 1999\u20132017, NCHS Data Brief no 329. 2018. https:\/\/www.cdc.gov\/nchs\/data\/databriefs\/db329-h.pdf. Accessed 28 July 2019."},{"issue":"2","key":"1236_CR14","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1016\/S2468-2667(18)30232-9","volume":"4","author":"B Fischer","year":"2019","unstructured":"Fischer B, Pang M, Tyndall M. The opioid death crisis in Canada: crucial lessons for public health. Lancet Public Health. 2019;4(2):e81\u20132. https:\/\/doi.org\/10.1016\/S2468-2667(18)30232-9.","journal-title":"Lancet Public Health."},{"key":"1236_CR15","unstructured":"Australian Institute of Health and Welfare. Opioid harm in Australia: and comparisons between Australia and Canada. 2018. https:\/\/www.aihw.gov.au\/reports\/illicit-use-of-drugs\/opioid-harm-in-australia\/contents\/summary. Accessed 28 July 2019."},{"key":"1236_CR16","unstructured":"Office for National Statistics. Deaths related to drug poisoning in England and Wales: 2017 registrations. 2018. https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/deaths\/bulletins\/deathsrelatedtodrugpoisoninginenglandandwales\/2017registrations. Accessed 28 July 2019."},{"key":"1236_CR17","unstructured":"National Institute on Drug Abuse. Increased drug availability is associated with increased use and overdose. 2018. https:\/\/www.drugabuse.gov\/publications\/research-reports\/relationship-between-prescription-drug-abuse-heroin-use\/increased-drug-availability-associated-increased-use-overdose. Accessed 29 Oct 2019."},{"issue":"1","key":"1236_CR18","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/bcp.12937","volume":"82","author":"EA Karanges","year":"2016","unstructured":"Karanges EA, Blanch B, Buckley NA, Pearson SA. Twenty-five years of prescription opioid use in Australia: a whole-of-population analysis using pharmaceutical claims. Br J Clin Pharmacol. 2016;82(1):255\u201367. https:\/\/doi.org\/10.1111\/bcp.12937.","journal-title":"Br J Clin Pharmacol"},{"key":"1236_CR19","unstructured":"Center for Disease Control and Prevention. U.S. opioid prescribing rate maps.\u00a02018. https:\/\/www.cdc.gov\/drugoverdose\/maps\/rxrate-maps.html. Accessed 28 July 2019."},{"key":"1236_CR20","doi-asserted-by":"crossref","unstructured":"Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and opioid-involved overdose deaths\u2014United States, 2013\u20132017. In: MMWR Morb Mortal Wkly Rep. 2019. https:\/\/www.cdc.gov\/mmwr\/volumes\/67\/wr\/mm675152e1.htm?s_cid=mm675152e1_w. Accessed 27 July 2019.","DOI":"10.15585\/mmwr.mm675152e1"},{"issue":"17","key":"1236_CR21","doi-asserted-by":"publisher","first-page":"388","DOI":"10.15585\/mmwr.mm6817a3","volume":"68","author":"M Kariisa","year":"2019","unstructured":"Kariisa M, Scholl L, Wilson N, Seth P, Hoots B. Drug overdose deaths involving cocaine and psychostimulants with abuse potential\u2014United States, 2003\u20132017. MMWR Morb Mortal Wkly Rep. 2019;68(17):388\u201395. https:\/\/doi.org\/10.15585\/mmwr.mm6817a3.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"1236_CR22","doi-asserted-by":"publisher","first-page":"e192851","DOI":"10.1001\/jamanetworkopen.2019.2851","volume":"2","author":"L LaRue","year":"2019","unstructured":"LaRue L, Twillman RK, Dawson E, Whitley P, Frasco MA, Huskey A, et al. Rate of fentanyl positivity among urine drug test results positive for cocaine or methamphetamine. JAMA Netw Open. 2019;2(4):e192851. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.2851.","journal-title":"JAMA Netw Open."},{"issue":"2","key":"1236_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/ADM.0000000000000380","volume":"12","author":"MM Bassiony","year":"2018","unstructured":"Bassiony MM, Abdelghani M, Salah El-Deen GM, Hassan MS, El-Gohari H, Youssef UM. Opioid use disorders attributed to tramadol among Egyptian University Students. J Addict Med. 2018;12(2):150\u20135. https:\/\/doi.org\/10.1097\/ADM.0000000000000380.","journal-title":"J Addict Med"},{"issue":"10134","key":"1236_CR24","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1016\/S0140-6736(18)31073-0","volume":"391","author":"L Salm-Reifferscheidt","year":"2018","unstructured":"Salm-Reifferscheidt L. Tramadol: Africa\u2019s opioid crisis. Lancet. 2018;391(10134):1982\u20133. https:\/\/doi.org\/10.1016\/S0140-6736(18)31073-0.","journal-title":"Lancet"},{"issue":"4","key":"1236_CR25","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/SLA.0000000000002117","volume":"265","author":"JF Waljee","year":"2017","unstructured":"Waljee JF, Cron DC, Steiger RM, Zhong L, Englesbe MJ, Brummett CM. Effect of preoperative opioid exposure on healthcare utilization and expenditures following elective abdominal surgery. Ann Surg. 2017;265(4):715\u201321. https:\/\/doi.org\/10.1097\/SLA.0000000000002117.","journal-title":"Ann Surg"},{"issue":"1","key":"1236_CR26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1213\/ANE.0000000000003338","volume":"127","author":"LK Dunn","year":"2018","unstructured":"Dunn LK, Yerra S, Fang S, Hanak MF, Leibowitz MK, Tsang S, et al. Incidence and risk factors for chronic postoperative opioid use after major spine surgery: a cross-sectional study with longitudinal outcome. Anesth Analg. 2018;127(1):247\u201354. https:\/\/doi.org\/10.1213\/ANE.0000000000003338.","journal-title":"Anesth Analg"},{"issue":"9","key":"1236_CR27","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1093\/pm\/pnw015","volume":"17","author":"SC Mudumbai","year":"2016","unstructured":"Mudumbai SC, Oliva EM, Lewis ET, Trafton J, Posner D, Mariano ER, et al. Time-to-cessation of postoperative opioids: a population-level analysis of the veterans affairs health care system. Pain Med. 2016;17(9):1732\u201343. https:\/\/doi.org\/10.1093\/pm\/pnw015.","journal-title":"Pain Med."},{"issue":"12","key":"1236_CR28","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1016\/j.arth.2017.08.010","volume":"32","author":"NA Bedard","year":"2017","unstructured":"Bedard NA, Pugely AJ, Dowdle SB, Duchman KR, Glass NA, Callaghan JJ. Opioid use following total hip arthroplasty: trends and risk factors for prolonged use. J Arthroplasty. 2017;32(12):3675\u20139. https:\/\/doi.org\/10.1016\/j.arth.2017.08.010.","journal-title":"J Arthroplasty"},{"issue":"8","key":"1236_CR29","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1016\/j.arth.2017.03.014","volume":"32","author":"NA Bedard","year":"2017","unstructured":"Bedard NA, Pugely AJ, Westermann RW, Duchman KR, Glass NA, Callaghan JJ. Opioid use after total knee arthroplasty: trends and risk factors for prolonged use. J Arthroplasty. 2017;32(8):2390\u20134. https:\/\/doi.org\/10.1016\/j.arth.2017.03.014.","journal-title":"J Arthroplasty"},{"issue":"10","key":"1236_CR30","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1001\/jamasurg.2018.2102","volume":"153","author":"PE Hilliard","year":"2018","unstructured":"Hilliard PE, Waljee J, Moser S, Metz L, Mathis M, Goesling J, et al. Prevalence of preoperative opioid use and characteristics associated with opioid use among patients presenting for surgery. JAMA Surg. 2018;153(10):929\u201337. https:\/\/doi.org\/10.1001\/jamasurg.2018.2102.","journal-title":"JAMA Surg."},{"key":"1236_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.1232","author":"CC Jorgensen","year":"2018","unstructured":"Jorgensen CC, Petersen M, Kehlet H, Aasvang EK. Analgesic consumption trajectories in 8975 patients 1\u00a0year after fast-track total hip or knee arthroplasty. Eur J Pain. 2018. https:\/\/doi.org\/10.1002\/ejp.1232.","journal-title":"Eur J Pain"},{"issue":"5","key":"1236_CR32","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1177\/0310057X1103900505","volume":"39","author":"CA Huxtable","year":"2011","unstructured":"Huxtable CA, Roberts LJ, Somogyi AA, Macintyre PE. Acute pain management in opioid-tolerant patients: a growing challenge. Anaesth Intensive Care. 2011;39(5):804\u201323.","journal-title":"Anaesth Intensive Care"},{"issue":"9","key":"1236_CR33","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1016\/j.arth.2017.04.002","volume":"32","author":"JC Rozell","year":"2017","unstructured":"Rozell JC, Courtney PM, Dattilo JR, Wu CH, Lee GC. Preoperative opiate use independently predicts narcotic consumption and complications after total joint arthroplasty. J Arthroplasty. 2017;32(9):2658\u201362. https:\/\/doi.org\/10.1016\/j.arth.2017.04.002.","journal-title":"J Arthroplasty"},{"issue":"8","key":"1236_CR34","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/j.arth.2016.01.032","volume":"31","author":"LE Hansen","year":"2016","unstructured":"Hansen LE, Stone GL, Matson CA, Tybor DJ, Pevear ME, Smith EL. Total Joint arthroplasty in patients taking methadone or buprenorphine\/naloxone preoperatively for prior heroin addiction: a prospective matched cohort study. J Arthroplasty. 2016;31(8):1698\u2013701. https:\/\/doi.org\/10.1016\/j.arth.2016.01.032.","journal-title":"J Arthroplasty"},{"issue":"6","key":"1236_CR35","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1097\/j.pain.0000000000000874","volume":"158","author":"TJ Hudson","year":"2017","unstructured":"Hudson TJ, Painter JT, Martin BC, Austen MA, Williams JS, Fortney JC, et al. Pharmacoepidemiologic analyses of opioid use among OEF\/OIF\/OND veterans. Pain. 2017;158(6):1039\u201345. https:\/\/doi.org\/10.1097\/j.pain.0000000000000874.","journal-title":"Pain"},{"issue":"1","key":"1236_CR36","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/j.pain.0000000000000730","volume":"158","author":"PD Quinn","year":"2017","unstructured":"Quinn PD, Hur K, Chang Z, Krebs EE, Bair MJ, Scott EL, et al. Incident and long-term opioid therapy among patients with psychiatric conditions and medications: a national study of commercial health care claims. Pain. 2017;158(1):140\u20138. https:\/\/doi.org\/10.1097\/j.pain.0000000000000730.","journal-title":"Pain"},{"issue":"6","key":"1236_CR37","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1111\/bcp.13556","volume":"84","author":"S Lalic","year":"2018","unstructured":"Lalic S, Gisev N, Bell JS, Korhonen MJ, Ilomaki J. Predictors of persistent prescription opioid analgesic use among people without cancer in Australia. Br J Clin Pharmacol. 2018;84(6):1267\u201378. https:\/\/doi.org\/10.1111\/bcp.13556.","journal-title":"Br J Clin Pharmacol"},{"issue":"15","key":"1236_CR38","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.2106\/JBJS.17.01239","volume":"100","author":"A Mohamadi","year":"2018","unstructured":"Mohamadi A, Chan JJ, Lian J, Wright CL, Marin AM, Rodriguez EK, et al. Risk factors and pooled rate of prolonged opioid use following trauma or surgery: a systematic review and meta-(regression) analysis. J Bone Joint Surg Am. 2018;100(15):1332\u201340. https:\/\/doi.org\/10.2106\/JBJS.17.01239.","journal-title":"J Bone Joint Surg Am"},{"issue":"9","key":"1236_CR39","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1097\/AJP.0000000000000603","volume":"34","author":"MD Sullivan","year":"2018","unstructured":"Sullivan MD. Depression effects on long-term prescription opioid use, abuse, and addiction. Clin J Pain. 2018;34(9):878\u201384. https:\/\/doi.org\/10.1097\/AJP.0000000000000603.","journal-title":"Clin J Pain"},{"issue":"6","key":"1236_CR40","doi-asserted-by":"publisher","first-page":"e170504","DOI":"10.1001\/jamasurg.2017.0504","volume":"152","author":"CM Brummett","year":"2017","unstructured":"Brummett CM, Waljee JF, Goesling J, Moser S, Lin P, Englesbe MJ, et al. New persistent opioid use after minor and major surgical procedures in US adults. JAMA Surg. 2017;152(6):e170504. https:\/\/doi.org\/10.1001\/jamasurg.2017.0504.","journal-title":"JAMA Surg."},{"issue":"8","key":"1236_CR41","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1016\/j.arth.2018.03.068","volume":"33","author":"RS Namba","year":"2018","unstructured":"Namba RS, Singh A, Paxton EW, Inacio MCS. Patient factors associated with prolonged postoperative opioid use after total knee arthroplasty. J Arthroplasty. 2018;33(8):2449\u201354. https:\/\/doi.org\/10.1016\/j.arth.2018.03.068.","journal-title":"J Arthroplasty"},{"key":"1236_CR42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13741-018-0105-8","volume":"7","author":"DI Rhon","year":"2018","unstructured":"Rhon DI, Snodgrass SJ, Cleland JA, Sissel CD, Cook CE. Predictors of chronic prescription opioid use after orthopedic surgery: derivation of a clinical prediction rule. Perioper Med (Lond). 2018;7:25. https:\/\/doi.org\/10.1186\/s13741-018-0105-8.","journal-title":"Perioper Med (Lond)."},{"issue":"14","key":"1236_CR43","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1111\/bph.13750","volume":"175","author":"LM Plein","year":"2018","unstructured":"Plein LM, Rittner HL. Opioids and the immune system\u2014friend or foe. Br J Pharmacol. 2018;175(14):2717\u201325. https:\/\/doi.org\/10.1111\/bph.13750.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"1236_CR44","doi-asserted-by":"publisher","first-page":"e640","DOI":"10.1097\/PR9.0000000000000640","volume":"3","author":"S Haroutounian","year":"2018","unstructured":"Haroutounian S. Postoperative opioids, endocrine changes, and immunosuppression. Pain Rep. 2018;3(2):e640. https:\/\/doi.org\/10.1097\/PR9.0000000000000640.","journal-title":"Pain Rep."},{"issue":"7","key":"1236_CR45","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1080\/17425255.2019.1634053","volume":"15","author":"F Khosrow-Khavar","year":"2019","unstructured":"Khosrow-Khavar F, Kurteva S, Cui Y, Filion KB, Douros A. Opioids and the risk of infection: a critical appraisal of the pharmacologic and clinical evidence. Expert Opin Drug Metab Toxicol. 2019;15(7):565\u201375. https:\/\/doi.org\/10.1080\/17425255.2019.1634053.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"7","key":"1236_CR46","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1007\/s11999-015-4173-5","volume":"473","author":"ME Menendez","year":"2015","unstructured":"Menendez ME, Ring D, Bateman BT. Preoperative opioid misuse is associated with increased morbidity and mortality after elective orthopaedic surgery. Clin Orthop Relat Res. 2015;473(7):2402\u201312. https:\/\/doi.org\/10.1007\/s11999-015-4173-5.","journal-title":"Clin Orthop Relat Res"},{"issue":"24","key":"1236_CR47","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1097\/brs.0000000000002714","volume":"43","author":"A Tank","year":"2018","unstructured":"Tank A, Hobbs J, Ramos E, Rubin DS. Opioid dependence and prolonged length of stay in lumbar fusion: a retrospective study utilizing the National Inpatient Sample 2003-2014. Spine (Phila Pa 1976). 2018;43(24):1739\u201345. https:\/\/doi.org\/10.1097\/brs.0000000000002714.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"10","key":"1236_CR48","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1016\/j.arth.2018.05.027","volume":"33","author":"KL Bell","year":"2018","unstructured":"Bell KL, Shohat N, Goswami K, Tan TL, Kalbian I, Parvizi J. Preoperative opioids increase the risk of periprosthetic joint infection after total joint arthroplasty. J Arthroplasty. 2018;33(10):3246\u20133251.e1. https:\/\/doi.org\/10.1016\/j.arth.2018.05.027.","journal-title":"J Arthroplasty."},{"issue":"6","key":"1236_CR49","doi-asserted-by":"publisher","first-page":"396","DOI":"10.7326\/M17-1907","volume":"168","author":"AD Wiese","year":"2018","unstructured":"Wiese AD, Griffin MR, Schaffner W, Stein CM, Greevy RA, Mitchel EF Jr, et al. Opioid analgesic use and risk for invasive pneumococcal diseases: a nested case-control study. Ann Intern Med. 2018;168(6):396\u2013404. https:\/\/doi.org\/10.7326\/M17-1907.","journal-title":"Ann Intern Med"},{"issue":"3","key":"1236_CR50","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1001\/jamainternmed.2018.6101","volume":"179","author":"EJ Edelman","year":"2019","unstructured":"Edelman EJ, Gordon KS, Crothers K, Akgun K, Bryant KJ, Becker WC, et al. Association of prescribed opioids with increased risk of community-acquired pneumonia among patients with and without HIV. JAMA Intern Med. 2019;179(3):297\u2013304. https:\/\/doi.org\/10.1001\/jamainternmed.2018.6101.","journal-title":"JAMA Intern Med."},{"issue":"2","key":"1236_CR51","doi-asserted-by":"publisher","first-page":"190","DOI":"10.4158\/EP14339.RA","volume":"21","author":"SP Demarest","year":"2015","unstructured":"Demarest SP, Gill RS, Adler RA. Opioid endocrinopathy. Endocr Pract. 2015;21(2):190\u20138. https:\/\/doi.org\/10.4158\/EP14339.RA.","journal-title":"Endocr Pract"},{"issue":"4","key":"1236_CR52","doi-asserted-by":"publisher","first-page":"R183","DOI":"10.1530\/EJE-18-0270","volume":"179","author":"A Fountas","year":"2018","unstructured":"Fountas A, Chai ST, Kourkouti C, Karavitaki N. Mechanisms of endocrinology: endocrinology of opioids. Eur J Endocrinol. 2018;179(4):R183\u201396. https:\/\/doi.org\/10.1530\/EJE-18-0270.","journal-title":"Eur J Endocrinol"},{"key":"1236_CR53","unstructured":"Food and Drug Administration. FDA Drug Safety Communication: FDA warns about several safety issues with opioid pain medicines; requires label changes. 2016. https:\/\/www.fda.gov\/media\/96472\/download. Accessed 27 July 2019."},{"issue":"4","key":"1236_CR54","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1097\/SLA.0000000000001901","volume":"265","author":"DC Cron","year":"2017","unstructured":"Cron DC, Englesbe MJ, Bolton CJ, Joseph MT, Carrier KL, Moser SE, et al. Preoperative opioid use is independently associated with increased costs and worse outcomes after major abdominal surgery. Ann Surg. 2017;265(4):695\u2013701. https:\/\/doi.org\/10.1097\/SLA.0000000000001901.","journal-title":"Ann Surg"},{"issue":"5","key":"1236_CR55","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1097\/ALN.0000000000002136","volume":"128","author":"A Gupta","year":"2018","unstructured":"Gupta A, Nizamuddin J, Elmofty D, Nizamuddin SL, Tung A, Minhaj M, et al. Opioid abuse or dependence increases 30-day readmission rates after major operating room procedures: a national readmissions database study. Anesthesiology. 2018;128(5):880\u201390. https:\/\/doi.org\/10.1097\/ALN.0000000000002136.","journal-title":"Anesthesiology"},{"issue":"5","key":"1236_CR56","doi-asserted-by":"publisher","first-page":"486e1\u2013e7","DOI":"10.1016\/j.ajog.2018.06.010","volume":"219","author":"CW Swenson","year":"2018","unstructured":"Swenson CW, Kamdar NS, Seiler K, Morgan DM, Lin P, As-Sanie S. Definition development and prevalence of new persistent opioid use following hysterectomy. Am J Obstet Gynecol. 2018;219(5):486e1\u2013e7. https:\/\/doi.org\/10.1016\/j.ajog.2018.06.010.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"1236_CR57","doi-asserted-by":"publisher","first-page":"355e","DOI":"10.1097\/01.prs.0000475788.52446.7b","volume":"137","author":"JF Waljee","year":"2016","unstructured":"Waljee JF, Zhong L, Hou H, Sears E, Brummett C, Chung KC. The use of opioid analgesics following common upper extremity surgical procedures: a National, population-based study. Plast Reconstr Surg. 2016;137(2):355e\u201364e. https:\/\/doi.org\/10.1097\/01.prs.0000475788.52446.7b.","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"1236_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2106\/JBJS.16.00167","volume":"99","author":"A Ben-Ari","year":"2017","unstructured":"Ben-Ari A, Chansky H, Rozet I. Preoperative opioid use is associated with early revision after total knee arthroplasty: a study of male patients treated in the veterans affairs system. J Bone Joint Surg Am. 2017;99(1):1\u20139. https:\/\/doi.org\/10.2106\/JBJS.16.00167.","journal-title":"J Bone Joint Surg Am"},{"issue":"11","key":"1236_CR59","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1016\/j.arth.2018.06.005","volume":"33","author":"NA Bedard","year":"2018","unstructured":"Bedard NA, DeMik DE, Dowdle SB, Owens JM, Liu SS, Callaghan JJ. Preoperative opioid use and its association with early revision of total knee arthroplasty. J Arthroplasty. 2018;33(11):3520\u20133. https:\/\/doi.org\/10.1016\/j.arth.2018.06.005.","journal-title":"J Arthroplasty"},{"issue":"7S","key":"1236_CR60","doi-asserted-by":"publisher","first-page":"S154","DOI":"10.1016\/j.arth.2018.01.018","volume":"33","author":"NA Bedard","year":"2018","unstructured":"Bedard NA, DeMik DE, Dowdle SB, Owens JM, Liu SS, Callaghan JJ. Does preoperative opioid use increase the risk of early revision total hip arthroplasty? J Arthroplasty. 2018;33(7S):S154\u20136. https:\/\/doi.org\/10.1016\/j.arth.2018.01.018.","journal-title":"J Arthroplasty"},{"issue":"2","key":"1236_CR61","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.arth.2017.09.001","volume":"33","author":"RS Namba","year":"2018","unstructured":"Namba RS, Inacio MCS, Pratt NL, Graves SE, Roughead EE, Paxton EW. Persistent opioid use following total knee arthroplasty: a signal for close surveillance. J Arthroplasty. 2018;33(2):331\u20136. https:\/\/doi.org\/10.1016\/j.arth.2017.09.001.","journal-title":"J Arthroplasty"},{"issue":"14","key":"1236_CR62","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.2106\/JBJS.17.01414","volume":"100","author":"J Weick","year":"2018","unstructured":"Weick J, Bawa H, Dirschl DR, Luu HH. Preoperative opioid use is associated with higher readmission and revision rates in total knee and total hip arthroplasty. J Bone Jt Surg Am. 2018;100(14):1171\u20136. https:\/\/doi.org\/10.2106\/JBJS.17.01414.","journal-title":"J Bone Jt Surg Am"},{"issue":"3","key":"1236_CR63","doi-asserted-by":"publisher","first-page":"137","DOI":"10.5312\/wjo.v10.i3.137","volume":"10","author":"RM Vakharia","year":"2019","unstructured":"Vakharia RM, Sabeh KG, Vakharia AM, Damodar DM, Law TY, Roche MW. Comparison of implant related complications amongst patients with opioid use disorder and non-users following total knee arthroplasty. World J Orthop. 2019;10(3):137\u201344. https:\/\/doi.org\/10.5312\/wjo.v10.i3.137.","journal-title":"World J Orthop."},{"issue":"5","key":"1236_CR64","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/ejp.1357","volume":"23","author":"J Bedson","year":"2019","unstructured":"Bedson J, Chen Y, Ashworth J, Hayward RA, Dunn KM, Jordan KP. Risk of adverse events in patients prescribed long-term opioids: a cohort study in the UK Clinical Practice Research Datalink. Eur J Pain. 2019;23(5):908\u201322. https:\/\/doi.org\/10.1002\/ejp.1357.","journal-title":"Eur J Pain"},{"issue":"11","key":"1236_CR65","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/j.spinee.2018.03.015","volume":"18","author":"N Jain","year":"2018","unstructured":"Jain N, Brock JL, Phillips FM, Weaver T, Khan SN. Chronic preoperative opioid use is a risk factor for increased complications, resource use, and costs after cervical fusion. Spine J. 2018;18(11):1989\u201398. https:\/\/doi.org\/10.1016\/j.spinee.2018.03.015.","journal-title":"Spine J."},{"issue":"19","key":"1236_CR66","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1097\/brs.0000000000002609","volume":"43","author":"N Jain","year":"2018","unstructured":"Jain N, Phillips FM, Weaver T, Khan SN. Preoperative chronic opioid therapy: a risk factor for complications, readmission, continued opioid use and increased costs after one- and two-level posterior lumbar fusion. Spine (Phila Pa 1976). 2018;43(19):1331\u20138. https:\/\/doi.org\/10.1097\/brs.0000000000002609.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"5","key":"1236_CR67","doi-asserted-by":"publisher","first-page":"384","DOI":"10.2106\/JBJS.18.00502","volume":"101","author":"N Jain","year":"2019","unstructured":"Jain N, Brock JL, Malik AT, Phillips FM, Khan SN. Prediction of complications, readmission, and revision surgery based on duration of preoperative opioid use: analysis of major joint replacement and lumbar fusion. J Bone Joint Surg Am. 2019;101(5):384\u201391. https:\/\/doi.org\/10.2106\/JBJS.18.00502.","journal-title":"J Bone Joint Surg Am"},{"issue":"5","key":"1236_CR68","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1213\/ANE.0000000000002280","volume":"125","author":"TR Vetter","year":"2017","unstructured":"Vetter TR, Kain ZN. Role of the perioperative surgical home in optimizing the perioperative use of opioids. Anesth Analg. 2017;125(5):1653\u20137. https:\/\/doi.org\/10.1213\/ANE.0000000000002280.","journal-title":"Anesth Analg"},{"issue":"2","key":"1236_CR69","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s40122-017-0079-0","volume":"6","author":"AD Kaye","year":"2017","unstructured":"Kaye AD, Helander EM, Vadivelu N, Lumermann L, Suchy T, Rose M, et al. Consensus statement for clinical pathway development for perioperative pain management and care transitions. Pain Ther. 2017;6(2):129\u201341. https:\/\/doi.org\/10.1007\/s40122-017-0079-0.","journal-title":"Pain Ther."},{"issue":"1","key":"1236_CR70","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.aan.2017.07.009","volume":"35","author":"JJ Pozek","year":"2017","unstructured":"Pozek JJ, Goldberg SF, Baratta JL, Schwenk ES. Practical management of the opioid-tolerant patient in the perioperative surgical home. Adv Anesth. 2017;35(1):175\u201390. https:\/\/doi.org\/10.1016\/j.aan.2017.07.009.","journal-title":"Adv Anesth"},{"issue":"2","key":"1236_CR71","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.anclin.2016.01.005","volume":"34","author":"JT Wenzel","year":"2016","unstructured":"Wenzel JT, Schwenk ES, Baratta JL, Viscusi ER. Managing opioid-tolerant patients in the perioperative surgical home. Anesthesiol Clin. 2016;34(2):287\u2013301. https:\/\/doi.org\/10.1016\/j.anclin.2016.01.005.","journal-title":"Anesthesiol Clin"},{"key":"1236_CR72","unstructured":"Royal College of Anaesthetists. Perioperative Medicine Programme. https:\/\/www.rcoa.ac.uk\/periopmed\/programme. Accessed 13 Aug 2019."},{"key":"1236_CR73","unstructured":"Australian and New Zealand College of Anaesthetists. Perioperative Medicine. http:\/\/www.anzca.edu.au\/about-anzca\/perioperative-medicine. Accessed 13 Aug 2019."},{"key":"1236_CR74","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.sjpain.2016.02.008","volume":"12","author":"E Tiippana","year":"2016","unstructured":"Tiippana E, Hamunen K, Heiskanen T, Nieminen T, Kalso E, Kontinen VK. New approach for treatment of prolonged postoperative pain: aPS Out-Patient Clinic. Scand J Pain. 2016;12:19\u201324. https:\/\/doi.org\/10.1016\/j.sjpain.2016.02.008.","journal-title":"Scand J Pain."},{"key":"1236_CR75","doi-asserted-by":"publisher","first-page":"695","DOI":"10.2147\/JPR.S91924","volume":"8","author":"J Katz","year":"2015","unstructured":"Katz J, Weinrib A, Fashler SR, Katznelzon R, Shah BR, Ladak SS, et al. The Toronto General Hospital Transitional Pain Service: development and implementation of a multidisciplinary program to prevent chronic postsurgical pain. J Pain Res. 2015;8:695\u2013702. https:\/\/doi.org\/10.2147\/JPR.S91924.","journal-title":"J Pain Res."},{"issue":"11","key":"1236_CR76","doi-asserted-by":"publisher","first-page":"752","DOI":"10.12788\/jhm.2993","volume":"13","author":"H Englander","year":"2018","unstructured":"Englander H, Collins D, Perry SP, Rabinowitz M, Phoutrides E, Nicolaidis C. \u201cWe\u2019ve Learned It\u2019s a medical illness, not a moral choice\u201d: qualitative study of the effects of a multicomponent addiction intervention on hospital providers\u2019 attitudes and experiences. J Hosp Med. 2018;13(11):752\u20138. https:\/\/doi.org\/10.12788\/jhm.2993.","journal-title":"J Hosp Med."},{"issue":"15","key":"1236_CR77","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2016.1464","volume":"315","author":"D Dowell","year":"2016","unstructured":"Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for Chronic Pain-United States, 2016. JAMA. 2016;315(15):1624\u201345. https:\/\/doi.org\/10.1001\/jama.2016.1464.","journal-title":"JAMA"},{"key":"1236_CR78","unstructured":"Institute for Healthcare Improvement. Advancing the safety of acute pain management. http:\/\/www.ihi.org\/resources\/Pages\/Publications\/Advancing-the-Safety-of-Acute-Pain-Management.aspx. Accessed 13 Aug 2019."},{"issue":"6","key":"1236_CR79","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.jemermed.2019.03.018","volume":"56","author":"CE Chalmers","year":"2019","unstructured":"Chalmers CE, Mullinax S, Brennan J, Vilke GM, Oliveto AH, Wilson MP. Screening tools validated in the outpatient pain management setting poorly predict opioid misuse in the emergency department: a pilot study. J Emerg Med. 2019;56(6):601\u201310. https:\/\/doi.org\/10.1016\/j.jemermed.2019.03.018.","journal-title":"J Emerg Med"},{"issue":"5","key":"1236_CR80","doi-asserted-by":"publisher","first-page":"e193365","DOI":"10.1001\/jamanetworkopen.2019.3365","volume":"2","author":"J Klimas","year":"2019","unstructured":"Klimas J, Gorfinkel L, Fairbairn N, Amato L, Ahamad K, Nolan S, et al. Strategies to identify patient risks of prescription opioid addiction when initiating opioids for pain: a systematic review. JAMA Netw Open. 2019;2(5):e193365. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.3365.","journal-title":"JAMA Netw Open."},{"issue":"6","key":"1236_CR81","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.mayocp.2015.04.003","volume":"90","author":"C Berna","year":"2015","unstructured":"Berna C, Kulich RJ, Rathmell JP. Tapering long-term opioid therapy in chronic noncancer pain: evidence and recommendations for everyday practice. Mayo Clin Proc. 2015;90(6):828\u201342. https:\/\/doi.org\/10.1016\/j.mayocp.2015.04.003.","journal-title":"Mayo Clin Proc"},{"key":"1236_CR82","doi-asserted-by":"publisher","first-page":"CD010323","DOI":"10.1002\/14651858.cd010323.pub3","volume":"11","author":"C Eccleston","year":"2017","unstructured":"Eccleston C, Fisher E, Thomas KH, Hearn L, Derry S, Stannard C, et al. Interventions for the reduction of prescribed opioid use in chronic non-cancer pain. Cochrane Database Syst Rev. 2017;11:CD010323. https:\/\/doi.org\/10.1002\/14651858.cd010323.pub3.","journal-title":"Cochrane Database Syst Rev."},{"key":"1236_CR83","unstructured":"US Department of Veterans Affairs. Opioid Taper Decision Tool. https:\/\/www.pbm.va.gov\/AcademicDetailingService\/Documents\/Pain_Opioid_Taper_Tool_IB_10_939_P96820.pdf. Accessed 13 Aug 2019."},{"key":"1236_CR84","unstructured":"National Prescribing Service. Lowering your opioid dose. https:\/\/www.nps.org.au\/assets\/NPS-MedicineWise-Lowering-your-opioid-dose.pdf?utm_medium=referral&utm_source=s-holders&utm_campaign=opioids&utm_content=pap. Accessed 29 Oct 2019."},{"key":"1236_CR85","unstructured":"National Prescribing Service. Starting a conversation about opioid tapering with patients. Practice tips for GPs and pharmacists. https:\/\/www.nps.org.au\/assets\/NPS_MedicineWise_Opioids_Conversation_Starter_FINAL.pdf?utm_medium=referral&utm_source=s-holders&utm_campaign=opioids&utm_content=resource. Accessed 29 Oct 2019."},{"key":"1236_CR86","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-019-00135-6","author":"JV Pergolizzi","year":"2019","unstructured":"Pergolizzi JV, Varrassi G, Paladini A, LeQuang J. Stopping or decreasing opioid therapy in patients on chronic opioid therapy. Pain Ther. 2019. https:\/\/doi.org\/10.1007\/s40122-019-00135-6.","journal-title":"Pain Ther"},{"issue":"3","key":"1236_CR87","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.bja.2017.11.098","volume":"120","author":"N Levy","year":"2018","unstructured":"Levy N, Sturgess J, Mills P. \u201cPain as the fifth vital sign\u201d and dependence on the \u201cnumerical pain scale\u201d is being abandoned in the US: why? Br J Anaesth. 2018;120(3):435\u20138. https:\/\/doi.org\/10.1016\/j.bja.2017.11.098.","journal-title":"Br J Anaesth"},{"issue":"2","key":"1236_CR88","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1213\/01.ANE.0000155970.45321.A8","volume":"101","author":"H Vila Jr","year":"2005","unstructured":"Vila H Jr, Smith RA, Augustyniak MJ, Nagi PA, Soto RG, Ross TW, et al. The efficacy and safety of pain management before and after implementation of hospital-wide pain management standards: is patient safety compromised by treatment based solely on numerical pain ratings? Anesth Analg. 2005;101(2):474\u201380.","journal-title":"Anesth Analg"},{"issue":"5","key":"1236_CR89","doi-asserted-by":"publisher","first-page":"e0177345","DOI":"10.1371\/journal.pone.0177345","volume":"12","author":"RLM van Boekel","year":"2017","unstructured":"van Boekel RLM, Vissers KCP, van der Sande R, Bronkhorst E, Lerou JGC, Steegers MAH. Moving beyond pain scores: multidimensional pain assessment is essential for adequate pain management after surgery. PLoS One. 2017;12(5):e0177345. https:\/\/doi.org\/10.1371\/journal.pone.0177345.","journal-title":"PLoS One"},{"issue":"2","key":"1236_CR90","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/ALN.0000000000000963","volume":"124","author":"CJ Hayhurst","year":"2016","unstructured":"Hayhurst CJ, Durieux ME. Differential opioid tolerance and opioid-induced hyperalgesia: a clinical reality. Anesthesiology. 2016;124(2):483\u20138. https:\/\/doi.org\/10.1097\/ALN.0000000000000963.","journal-title":"Anesthesiology"},{"issue":"2","key":"1236_CR91","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0304-3959(94)00168-E","volume":"61","author":"SE Rapp","year":"1995","unstructured":"Rapp SE, Ready LB, Nessly ML. Acute pain management in patients with prior opioid consumption: a case-controlled retrospective review. Pain. 1995;61(2):195\u2013201.","journal-title":"Pain"},{"issue":"2","key":"1236_CR92","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1177\/0310057X1304100212","volume":"41","author":"P Macintyre","year":"2013","unstructured":"Macintyre P, Russell R, Usher K, Gaughwin M, Huxtable C. Pain relief and opioid requirements in the first 24 hours after surgery in patients taking buprenorphine and methadone opioid substitution therapy. Anaesth Intensive Care. 2013;41(2):222\u201330.","journal-title":"Anaesth Intensive Care"},{"issue":"4","key":"1236_CR93","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.chest.2016.05.022","volume":"150","author":"E Van Ryswyk","year":"2016","unstructured":"Van Ryswyk E, Antic NA. Opioids and sleep-disordered breathing. Chest. 2016;150(4):934\u201344. https:\/\/doi.org\/10.1016\/j.chest.2016.05.022.","journal-title":"Chest"},{"issue":"6","key":"1236_CR94","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1213\/ANE.0000000000000774","volume":"120","author":"F Chung","year":"2015","unstructured":"Chung F, Liao P, Yang Y, Andrawes M, Kang W, Mokhlesi B, et al. Postoperative sleep-disordered breathing in patients without preoperative sleep apnea. Anesth Analg. 2015;120(6):1214\u201324. https:\/\/doi.org\/10.1213\/ANE.0000000000000774.","journal-title":"Anesth Analg"},{"issue":"4","key":"1236_CR95","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jpainsymman.2017.07.013","volume":"54","author":"PM Patel","year":"2017","unstructured":"Patel PM, Goodman LF, Knepel SA, Miller CC, Azimi A, Phillips G, et al. Evaluation of emergency department management of opioid-tolerant cancer patients with acute pain. J Pain Symptom Manag. 2017;54(4):501\u20137. https:\/\/doi.org\/10.1016\/j.jpainsymman.2017.07.013.","journal-title":"J Pain Symptom Manag"},{"key":"1236_CR96","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.2147\/TCRM.S141332","volume":"13","author":"F Coluzzi","year":"2017","unstructured":"Coluzzi F, Bifulco F, Cuomo A, Dauri M, Leonardi C, Melotti RM, et al. The challenge of perioperative pain management in opioid-tolerant patients. Ther Clin Risk Manag. 2017;13:1163\u201373. https:\/\/doi.org\/10.2147\/TCRM.S141332.","journal-title":"Ther Clin Risk Manag"},{"issue":"2","key":"1236_CR97","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.pmr.2014.12.001","volume":"26","author":"JC Ballantyne","year":"2015","unstructured":"Ballantyne JC. Opioid therapy in chronic pain. Phys Med Rehabil Clin N Am. 2015;26(2):201\u201318. https:\/\/doi.org\/10.1016\/j.pmr.2014.12.001.","journal-title":"Phys Med Rehabil Clin N Am"},{"issue":"9","key":"1236_CR98","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1111\/pme.12773","volume":"16","author":"G Campbell","year":"2015","unstructured":"Campbell G, Nielsen S, Larance B, Bruno R, Mattick R, Hall W, et al. Pharmaceutical opioid use and dependence among people living with chronic pain: associations observed within the pain and opioids in treatment (POINT) Cohort. Pain Med. 2015;16(9):1745\u201358. https:\/\/doi.org\/10.1111\/pme.12773.","journal-title":"Pain Med."},{"issue":"3","key":"1236_CR99","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1097\/ALN.0000000000000530","volume":"122","author":"NP Katz","year":"2015","unstructured":"Katz NP, Paillard FC, Edwards RR. Review of the performance of quantitative sensory testing methods to detect hyperalgesia in chronic pain patients on long-term opioids. Anesthesiology. 2015;122(3):677\u201385. https:\/\/doi.org\/10.1097\/ALN.0000000000000530.","journal-title":"Anesthesiology"},{"issue":"6","key":"1236_CR100","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1093\/bja\/aeu137","volume":"112","author":"D Fletcher","year":"2014","unstructured":"Fletcher D, Martinez V. Opioid-induced hyperalgesia in patients after surgery: a systematic review and a meta-analysis. Br J Anaesth. 2014;112(6):991\u20131004. https:\/\/doi.org\/10.1093\/bja\/aeu137.","journal-title":"Br J Anaesth"},{"issue":"4","key":"1236_CR101","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.jclinane.2015.03.020","volume":"27","author":"L Wu","year":"2015","unstructured":"Wu L, Huang X, Sun L. The efficacy of N-methyl-D-aspartate receptor antagonists on improving the postoperative pain intensity and satisfaction after remifentanil-based anesthesia in adults: a meta-analysis. J Clin Anesth. 2015;27(4):311\u201324. https:\/\/doi.org\/10.1016\/j.jclinane.2015.03.020.","journal-title":"J Clin Anesth"},{"issue":"9","key":"1236_CR102","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1002\/ejp.870","volume":"20","author":"A Wehrfritz","year":"2016","unstructured":"Wehrfritz A, Schaefer S, Troester A, Noel N, Bessiere B, Apiou-Sbirlea G, et al. A randomized phase I trial evaluating the effects of inhaled 50-50% N2 O-O2 on remifentanil-induced hyperalgesia and allodynia in human volunteers. Eur J Pain. 2016;20(9):1467\u201377. https:\/\/doi.org\/10.1002\/ejp.870.","journal-title":"Eur J Pain"},{"issue":"9","key":"1236_CR103","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/aas.12560","volume":"59","author":"Y Xiao","year":"2015","unstructured":"Xiao Y, Wu L, Zhou Q, Xiong W, Duan X, Huang X. A randomized clinical trial of the effects of ultra-low-dose naloxone infusion on postoperative opioid requirements and recovery. Acta Anaesthesiol Scand. 2015;59(9):1194\u2013203. https:\/\/doi.org\/10.1111\/aas.12560.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"6","key":"1236_CR104","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1097\/ALN.0000000000001633","volume":"126","author":"TA Anderson","year":"2017","unstructured":"Anderson TA, Quaye ANA, Ward EN, Wilens TE, Hilliard PE, Brummett CM. To stop or not, that is the question: acute pain management for the patient on chronic buprenorphine. Anesthesiology. 2017;126(6):1180\u20136. https:\/\/doi.org\/10.1097\/ALN.0000000000001633.","journal-title":"Anesthesiology"},{"issue":"7","key":"1236_CR105","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1093\/pm\/pny217","volume":"20","author":"ANA Quaye","year":"2019","unstructured":"Quaye ANA, Zhang Y. Perioperative management of buprenorphine: solving the conundrum. Pain Med. 2019;20(7):1395\u2013408.","journal-title":"Pain Med"},{"issue":"3","key":"1236_CR106","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.anclin.2018.04.002","volume":"36","author":"TK Harrison","year":"2018","unstructured":"Harrison TK, Kornfeld H, Aggarwal AK, Lembke A. Perioperative considerations for the patient with opioid use disorder on buprenorphine, methadone, or naltrexone maintenance therapy. Anesthesiol Clin. 2018;36(3):345\u201359. https:\/\/doi.org\/10.1016\/j.anclin.2018.04.002.","journal-title":"Anesthesiol Clin."},{"issue":"3","key":"1236_CR107","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/pm\/pny019","volume":"20","author":"A Lembke","year":"2019","unstructured":"Lembke A, Ottestad E, Schmiesing C. Patients maintained on buprenorphine for opioid use disorder should continue buprenorphine through the perioperative period. Pain Med. 2019;20(3):425\u20138. https:\/\/doi.org\/10.1093\/pm\/pny019.","journal-title":"Pain Med."},{"issue":"2","key":"1236_CR108","doi-asserted-by":"publisher","first-page":"e333","DOI":"10.1016\/j.bja.2019.03.044","volume":"123","author":"A Goel","year":"2019","unstructured":"Goel A, Azargive S, Weissman JS, Shanthanna H, Hanlon JG, Samman B, et al. Perioperative Pain and Addiction Interdisciplinary Network (PAIN) clinical practice advisory for perioperative management of buprenorphine: results of a modified Delphi process. Br J Anaesth. 2019;123(2):e333\u201342. https:\/\/doi.org\/10.1016\/j.bja.2019.03.044.","journal-title":"Br J Anaesth"},{"issue":"5","key":"1236_CR109","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1213\/ANE.0000000000002498","volume":"125","author":"BL Leighton","year":"2017","unstructured":"Leighton BL, Crock LW. case series of successful postoperative pain management in buprenorphine maintenance therapy patients. Anesth Analg. 2017;125(5):1779\u201383. https:\/\/doi.org\/10.1213\/ANE.0000000000002498.","journal-title":"Anesth Analg"},{"issue":"11","key":"1236_CR110","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1080\/03007995.2017.1379981","volume":"33","author":"S Mercadante","year":"2017","unstructured":"Mercadante S. The role of tapentadol as a strong opioid in cancer pain management: a systematic and critical review. Curr Med Res Opin. 2017;33(11):1965\u20139. https:\/\/doi.org\/10.1080\/03007995.2017.1379981.","journal-title":"Curr Med Res Opin"},{"issue":"8","key":"1236_CR111","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1093\/pm\/pnv032","volume":"17","author":"RC Dart","year":"2016","unstructured":"Dart RC, Surratt HL, Le Lait MC, Stivers Y, Bebarta VS, Freifeld CC, et al. Diversion and illicit sale of extended release tapentadol in the United States. Pain Med. 2016;17(8):1490\u20136. https:\/\/doi.org\/10.1093\/pm\/pnv032.","journal-title":"Pain Med"},{"issue":"4","key":"1236_CR112","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jpain.2017.11.007","volume":"19","author":"SK Vosburg","year":"2018","unstructured":"Vosburg SK, Severtson SG, Dart RC, Cicero TJ, Kurtz SP, Parrino MW, et al. Assessment of tapentadol API abuse liability with the researched abuse, diversion and addiction-related surveillance system. J Pain. 2018;19(4):439\u201353. https:\/\/doi.org\/10.1016\/j.jpain.2017.11.007.","journal-title":"J Pain."},{"issue":"12","key":"1236_CR113","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1097\/AJP.0000000000000067","volume":"30","author":"MS Cepeda","year":"2014","unstructured":"Cepeda MS, Fife D, Kihm MA, Mastrogiovanni G, Yuan Y. Comparison of the risks of shopping behavior and opioid abuse between tapentadol and oxycodone and association of shopping behavior and opioid abuse. Clin J Pain. 2014;30(12):1051\u20136. https:\/\/doi.org\/10.1097\/AJP.0000000000000067.","journal-title":"Clin J Pain"},{"issue":"10","key":"1236_CR114","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1080\/17460441.2018.1511539","volume":"13","author":"JV Pergolizzi Jr","year":"2018","unstructured":"Pergolizzi JV Jr, LeQuang JA, Taylor R Jr, Ossipov MH, Colucci D, Raffa RB. Designing safer analgesics: a focus on mu-opioid receptor pathways. Expert Opin Drug Discov. 2018;13(10):965\u201372. https:\/\/doi.org\/10.1080\/17460441.2018.1511539.","journal-title":"Expert Opin Drug Discov"},{"issue":"3","key":"1236_CR115","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1097\/ALN.0b013e3181e90914","volume":"113","author":"RW Loftus","year":"2010","unstructured":"Loftus RW, Yeager MP, Clark JA, Brown JR, Abdu WA, Sengupta DK, et al. Intraoperative ketamine reduces perioperative opiate consumption in opiate-dependent patients with chronic back pain undergoing back surgery. Anesthesiology. 2010;113(3):639\u201346. https:\/\/doi.org\/10.1097\/ALN.0b013e3181e90914.","journal-title":"Anesthesiology"},{"issue":"1","key":"1236_CR116","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/EJA.0000000000000877","volume":"36","author":"K Boenigk","year":"2019","unstructured":"Boenigk K, Echevarria GC, Nisimov E, von Bergen Granell AE, Cuff GE, Wang J, et al. Low-dose ketamine infusion reduces postoperative hydromorphone requirements in opioid-tolerant patients following spinal fusion: a randomised controlled trial. Eur J Anaesthesiol. 2019;36(1):8\u201315. https:\/\/doi.org\/10.1097\/EJA.0000000000000877.","journal-title":"Eur J Anaesthesiol"},{"issue":"1","key":"1236_CR117","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s11420-007-9069-9","volume":"4","author":"MK Urban","year":"2008","unstructured":"Urban MK, Ya Deau JT, Wukovits B, Lipnitsky JY. Ketamine as an adjunct to postoperative pain management in opioid tolerant patients after spinal fusions: a prospective randomized trial. HSS J. 2008;4(1):62\u20135. https:\/\/doi.org\/10.1007\/s11420-007-9069-9.","journal-title":"HSS J."},{"issue":"6","key":"1236_CR118","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/pme.12086","volume":"14","author":"AM Barreveld","year":"2013","unstructured":"Barreveld AM, Correll DJ, Liu X, Max B, McGowan JA, Shovel L, et al. Ketamine decreases postoperative pain scores in patients taking opioids for chronic pain: results of a prospective, randomized, double-blind study. Pain Med. 2013;14(6):925\u201334. https:\/\/doi.org\/10.1111\/pme.12086.","journal-title":"Pain Med."},{"issue":"3","key":"1236_CR119","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/j.pain.0000000000000782","volume":"158","author":"RV Nielsen","year":"2017","unstructured":"Nielsen RV, Fomsgaard JS, Siegel H, Martusevicius R, Nikolajsen L, Dahl JB, et al. Intraoperative ketamine reduces immediate postoperative opioid consumption after spinal fusion surgery in chronic pain patients with opioid dependency: a randomized, blinded trial. Pain. 2017;158(3):463\u201370. https:\/\/doi.org\/10.1097\/j.pain.0000000000000782.","journal-title":"Pain"},{"issue":"3","key":"1236_CR120","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/ejp.1317","volume":"23","author":"RV Nielsen","year":"2019","unstructured":"Nielsen RV, Fomsgaard JS, Nikolajsen L, Dahl JB, Mathiesen O. Intraoperative S-ketamine for the reduction of opioid consumption and pain one year after spine surgery: a randomized clinical trial of opioid-dependent patients. Eur J Pain. 2019;23(3):455\u201360. https:\/\/doi.org\/10.1002\/ejp.1317.","journal-title":"Eur J Pain"},{"issue":"5","key":"1236_CR121","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1097\/AAP.0000000000000806","volume":"43","author":"ES Schwenk","year":"2018","unstructured":"Schwenk ES, Viscusi ER, Buvanendran A, Hurley RW, Wasan AD, Narouze S, et al. Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Acute Pain Management From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists. Reg Anesth Pain Med. 2018;43(5):456\u201366. https:\/\/doi.org\/10.1097\/AAP.0000000000000806.","journal-title":"Reg Anesth Pain Med"},{"issue":"10","key":"1236_CR122","doi-asserted-by":"publisher","first-page":"22","DOI":"10.11124\/JBISRIR-2016-003160","volume":"14","author":"M Bennett","year":"2016","unstructured":"Bennett M, Bonanno L, Kuhn W. Effectiveness of ketamine as an adjuvant to opioid-based therapy in decreasing pain associated with opioid tolerance in adults undergoing orthopedic surgery: a systematic review protocol. JBI Database Syst Rev Implement Rep. 2016;14(10):22\u20138. https:\/\/doi.org\/10.11124\/JBISRIR-2016-003160.","journal-title":"JBI Database Syst Rev Implement Rep"},{"issue":"8","key":"1236_CR123","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/da.22536","volume":"33","author":"S Sassano-Higgins","year":"2016","unstructured":"Sassano-Higgins S, Baron D, Juarez G, Esmaili N, Gold M. A review of ketamine abuse and diversion. Depress Anxiety. 2016;33(8):718\u201327. https:\/\/doi.org\/10.1002\/da.22536.","journal-title":"Depress Anxiety"},{"key":"1236_CR124","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ejphar.2014.08.030","volume":"742","author":"P Hasanein","year":"2014","unstructured":"Hasanein P, Shakeri S. Pregabalin role in inhibition of morphine analgesic tolerance and physical dependency in rats. Eur J Pharmacol. 2014;742:113\u20137. https:\/\/doi.org\/10.1016\/j.ejphar.2014.08.030.","journal-title":"Eur J Pharmacol"},{"issue":"13","key":"1236_CR125","first-page":"2503","volume":"19","author":"KR Savic Vujovic","year":"2015","unstructured":"Savic Vujovic KR, Vuckovic S, Srebro D, Medic B, Stojanovic R, Vucetic C, et al. A synergistic interaction between magnesium sulphate and ketamine on the inhibition of acute nociception in rats. Eur Rev Med Pharmacol Sci. 2015;19(13):2503\u20139.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1236_CR126","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ejps.2016.11.020","volume":"99","author":"M Bujalska-Zadrozny","year":"2017","unstructured":"Bujalska-Zadrozny M, Tatarkiewicz J, Kulik K, Filip M, Naruszewicz M. Magnesium enhances opioid-induced analgesia\u2014what we have learnt in the past decades? Eur J Pharm Sci. 2017;99:113\u201327. https:\/\/doi.org\/10.1016\/j.ejps.2016.11.020.","journal-title":"Eur J Pharm Sci"},{"issue":"5","key":"1236_CR127","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1155\/2011\/561604","volume":"16","author":"N Eipe","year":"2011","unstructured":"Eipe N, Penning J. Postoperative respiratory depression with pregabalin: a case series and a preoperative decision algorithm. Pain Res Manag. 2011;16(5):353\u20136.","journal-title":"Pain Res Manag"},{"issue":"1","key":"1236_CR128","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1213\/ANE.0000000000001719","volume":"125","author":"AN Cavalcante","year":"2017","unstructured":"Cavalcante AN, Sprung J, Schroeder DR, Weingarten TN. Multimodal analgesic therapy with gabapentin and its association with postoperative respiratory depression. Anesth Analg. 2017;125(1):141\u20136. https:\/\/doi.org\/10.1213\/ANE.0000000000001719.","journal-title":"Anesth Analg"},{"issue":"4","key":"1236_CR129","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/AAP.0000000000000257","volume":"40","author":"TN Weingarten","year":"2015","unstructured":"Weingarten TN, Jacob AK, Njathi CW, Wilson GA, Sprung J. Multimodal analgesic protocol and postanesthesia respiratory depression during phase i recovery after total joint arthroplasty. Reg Anesth Pain Med. 2015;40(4):330\u20136. https:\/\/doi.org\/10.1097\/AAP.0000000000000257.","journal-title":"Reg Anesth Pain Med"},{"issue":"7","key":"1236_CR130","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/add.13324","volume":"111","author":"RV Smith","year":"2016","unstructured":"Smith RV, Havens JR, Walsh SL. Gabapentin misuse, abuse and diversion: a systematic review. Addiction. 2016;111(7):1160\u201374. https:\/\/doi.org\/10.1111\/add.13324.","journal-title":"Addiction"},{"issue":"4","key":"1236_CR131","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s40265-017-0700-x","volume":"77","author":"KE Evoy","year":"2017","unstructured":"Evoy KE, Morrison MD, Saklad SR. Abuse and misuse of pregabalin and gabapentin. Drugs. 2017;77(4):403\u201326. https:\/\/doi.org\/10.1007\/s40265-017-0700-x.","journal-title":"Drugs."},{"issue":"2","key":"1236_CR132","doi-asserted-by":"publisher","first-page":"75","DOI":"10.5694\/mja2.12036","volume":"210","author":"R Crossin","year":"2019","unstructured":"Crossin R, Scott D, Arunogiri S, Smith K, Dietze PM, Lubman DI. Pregabalin misuse-related ambulance attendances in Victoria, 2012-2017: characteristics of patients and attendances. Med J Aust. 2019;210(2):75\u20139. https:\/\/doi.org\/10.5694\/mja2.12036.","journal-title":"Med J Aust"},{"issue":"6","key":"1236_CR133","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1111\/add.14412","volume":"114","author":"R Cairns","year":"2019","unstructured":"Cairns R, Schaffer AL, Ryan N, Pearson SA, Buckley NA. Rising pregabalin use and misuse in Australia: trends in utilization and intentional poisonings. Addiction. 2019;114(6):1026\u201334. https:\/\/doi.org\/10.1111\/add.14412.","journal-title":"Addiction"},{"issue":"10","key":"1236_CR134","doi-asserted-by":"publisher","first-page":"732","DOI":"10.7326\/M18-1136","volume":"169","author":"T Gomes","year":"2018","unstructured":"Gomes T, Greaves S, van den Brink W, Antoniou T, Mamdani MM, Paterson JM, et al. Pregabalin and the risk for opioid-related death: a nested case-control study. Ann Intern Med. 2018;169(10):732\u20134. https:\/\/doi.org\/10.7326\/M18-1136.","journal-title":"Ann Intern Med"},{"issue":"2S","key":"1236_CR135","first-page":"S111","volume":"20","author":"AD Kaye","year":"2017","unstructured":"Kaye AD, Jones MR, Kaye AM, Ripoll JG, Jones DE, Galan V, et al. Prescription opioid abuse in chronic pain: an updated review of opioid abuse predictors and strategies to curb opioid abuse (Part 2). Pain Physician. 2017;20(2S):S111\u201333.","journal-title":"Pain Physician."},{"issue":"17\u201318","key":"1236_CR136","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1503\/cmaj.160290","volume":"188","author":"JH Donroe","year":"2016","unstructured":"Donroe JH, Holt SR, Tetrault JM. Caring for patients with opioid use disorder in the hospital. CMAJ. 2016;188(17\u201318):1232\u20139. https:\/\/doi.org\/10.1503\/cmaj.160290.","journal-title":"CMAJ"},{"key":"1236_CR137","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.drugalcdep.2014.11.031","volume":"147","author":"L Degenhardt","year":"2015","unstructured":"Degenhardt L, Lintzeris N, Campbell G, Bruno R, Cohen M, Farrell M, et al. Experience of adjunctive cannabis use for chronic non-cancer pain: findings from the Pain and Opioids IN Treatment (POINT) study. Drug Alcohol Depend. 2015;147:144\u201350. https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.11.031.","journal-title":"Drug Alcohol Depend"},{"key":"1236_CR138","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2147\/SAR.S109576","volume":"8","author":"U Bonnet","year":"2017","unstructured":"Bonnet U, Preuss UW. The cannabis withdrawal syndrome: current insights. Subst Abuse Rehabil. 2017;8:9\u201337. https:\/\/doi.org\/10.2147\/SAR.S109576.","journal-title":"Subst Abuse Rehabil"},{"key":"1236_CR139","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd002024.pub4","author":"L Gowing","year":"2014","unstructured":"Gowing L, Farrell MF, Ali R, White JM. Alpha2-adrenergic agonists for the management of opioid withdrawal. Cochrane Database Syst Rev. 2014. https:\/\/doi.org\/10.1002\/14651858.cd002024.pub4.","journal-title":"Cochrane Database Syst Rev."},{"key":"1236_CR140","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-018-0095-8","author":"JV Pergolizzi Jr","year":"2018","unstructured":"Pergolizzi JV Jr, Taylor R Jr, LeQuang JA, Raffa RB, Bisney J. Tapentadol extended release in the treatment of severe chronic low back pain and osteoarthritis pain. Pain Ther. 2018. https:\/\/doi.org\/10.1007\/s40122-018-0095-8.","journal-title":"Pain Ther"},{"key":"1236_CR141","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2015.12.008","author":"R Chou","year":"2016","unstructured":"Chou R, Gordon DB, de Leon-Casasola OA, Rosenberg JM, Bickler S, Brennan T, et al. Management of Postoperative Pain: a Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists\u2019 Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain. 2016. https:\/\/doi.org\/10.1016\/j.jpain.2015.12.008.","journal-title":"J Pain"},{"key":"1236_CR142","unstructured":"Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine. Statement on the use of slow-release opioid preparations in the treatment of acute pain. 2018. http:\/\/www.anzca.edu.au\/resources\/endorsed-guidelines\/position-statement-on-the-use-of-slow-release-opio. Accessed 14 June 2018."},{"issue":"10180","key":"1236_CR143","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/S0140-6736(19)30428-3","volume":"393","author":"MD Neuman","year":"2019","unstructured":"Neuman MD, Bateman BT, Wunsch H. Inappropriate opioid prescription after surgery. Lancet. 2019;393(10180):1547\u201357. https:\/\/doi.org\/10.1016\/S0140-6736(19)30428-3.","journal-title":"Lancet"},{"issue":"1","key":"1236_CR144","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.arth.2017.08.022","volume":"33","author":"K Hadlandsmyth","year":"2018","unstructured":"Hadlandsmyth K, Vander Weg MW, McCoy KD, Mosher HJ, Vaughan-Sarrazin MS, Lund BC. Risk for prolonged opioid use following total knee arthroplasty in veterans. J Arthroplasty. 2018;33(1):119\u201323. https:\/\/doi.org\/10.1016\/j.arth.2017.08.022.","journal-title":"J Arthroplasty"},{"issue":"1","key":"1236_CR145","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.arth.2017.07.041","volume":"33","author":"KY Kim","year":"2018","unstructured":"Kim KY, Anoushiravani AA, Chen KK, Roof M, Long WJ, Schwarzkopf R. Preoperative chronic opioid users in total knee arthroplasty-which patients persistently abuse opiates following surgery? J Arthroplasty. 2018;33(1):107\u201312. https:\/\/doi.org\/10.1016\/j.arth.2017.07.041.","journal-title":"J Arthroplasty"},{"issue":"11","key":"1236_CR146","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1001\/jamasurg.2017.0831","volume":"152","author":"MC Bicket","year":"2017","unstructured":"Bicket MC, Long JJ, Pronovost PJ, Alexander GC, Wu CL. Prescription opioid analgesics commonly unused after surgery: a systematic review. JAMA Surg. 2017;152(11):1066\u201371. https:\/\/doi.org\/10.1001\/jamasurg.2017.0831.","journal-title":"JAMA Surg"},{"issue":"6","key":"1236_CR147","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1097\/sla.0000000000002591","volume":"267","author":"AE Feinberg","year":"2018","unstructured":"Feinberg AE, Chesney TR, Srikandarajah S, Acuna SA, McLeod RS, Best Practice in Surgery G. Opioid use after discharge in postoperative patients: a systematic review. Ann Surg. 2018;267(6):1056\u201362. https:\/\/doi.org\/10.1097\/sla.0000000000002591.","journal-title":"Ann Surg"},{"issue":"3","key":"1236_CR148","doi-asserted-by":"publisher","first-page":"180","DOI":"10.2106\/JBJS.17.00672","volume":"100","author":"MJ Sabatino","year":"2018","unstructured":"Sabatino MJ, Kunkel ST, Ramkumar DB, Keeney BJ, Jevsevar DS. Excess opioid medication and variation in prescribing patterns following common orthopaedic procedures. J Bone Jt Surg Am. 2018;100(3):180\u20138. https:\/\/doi.org\/10.2106\/JBJS.17.00672.","journal-title":"J Bone Jt Surg Am"},{"issue":"6","key":"1236_CR149","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.jamcollsurg.2017.10.012","volume":"226","author":"MV Hill","year":"2018","unstructured":"Hill MV, Stucke RS, Billmeier SE, Kelly JL, Barth RJ Jr. Guideline for discharge opioid prescriptions after inpatient general surgical procedures. J Am Coll Surg. 2018;226(6):996\u20131003. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2017.10.012.","journal-title":"J Am Coll Surg"},{"issue":"7","key":"1236_CR150","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1056\/NEJMc1905045","volume":"381","author":"JV Vu","year":"2019","unstructured":"Vu JV, Howard RA, Gunaseelan V, Brummett CM, Waljee JF, Englesbe MJ. Statewide implementation of postoperative opioid prescribing guidelines. N Engl J Med. 2019;381(7):680\u20132. https:\/\/doi.org\/10.1056\/NEJMc1905045.","journal-title":"N Engl J Med"},{"issue":"3","key":"1236_CR151","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1097\/AOG.0000000000002782","volume":"132","author":"SS Osmundson","year":"2018","unstructured":"Osmundson SS, Raymond BL, Kook BT, Lam L, Thompson EB, Schornack LA, et al. Individualized compared with standard postdischarge oxycodone prescribing after cesarean birth: a randomized controlled trial. Obstet Gynecol. 2018;132(3):624\u201330. https:\/\/doi.org\/10.1097\/AOG.0000000000002782.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"1236_CR152","doi-asserted-by":"publisher","first-page":"e174859","DOI":"10.1001\/jamasurg.2017.4859","volume":"153","author":"EY Chen","year":"2018","unstructured":"Chen EY, Marcantonio A, Tornetta P 3rd. Correlation between 24-hour predischarge opioid use and amount of opioids prescribed at hospital discharge. JAMA Surg. 2018;153(2):e174859. https:\/\/doi.org\/10.1001\/jamasurg.2017.4859.","journal-title":"JAMA Surg"},{"issue":"1","key":"1236_CR153","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1080\/24740527.2018.1501669","volume":"2","author":"H Clarke","year":"2018","unstructured":"Clarke H, Azargive S, Montbriand J, Nicholls J, Sutherland A, Valeeva L, et al. Opioid weaning and pain management in postsurgical patients at the Toronto General Hospital Transitional Pain Service. Can J Pain. 2018;2(1):236\u201357. https:\/\/doi.org\/10.1080\/24740527.2018.1501669.","journal-title":"Can J Pain"},{"issue":"11","key":"1236_CR154","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.jpain.2017.06.010","volume":"18","author":"A Shah","year":"2017","unstructured":"Shah A, Hayes CJ, Martin BC. Factors Influencing long-term opioid use among opioid naive patients: an examination of initial prescription characteristics and pain etiologies. J Pain. 2017;18(11):1374\u201383. https:\/\/doi.org\/10.1016\/j.jpain.2017.06.010.","journal-title":"J Pain"},{"issue":"2","key":"1236_CR155","doi-asserted-by":"publisher","first-page":"e188081","DOI":"10.1001\/jamanetworkopen.2018.8081","volume":"2","author":"S Chihuri","year":"2019","unstructured":"Chihuri S, Li G. Use of prescription opioids and initiation of fatal 2-vehicle crashes. JAMA Netw Open. 2019;2(2):e188081. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.8081.","journal-title":"JAMA Netw Open"},{"key":"1236_CR156","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.aap.2018.08.026","volume":"121","author":"CM Wickens","year":"2018","unstructured":"Wickens CM, Mann RE, Brands B, Ialomiteanu AR, Fischer B, Watson TM, et al. Driving under the influence of prescription opioids: self-reported prevalence and association with collision risk in a large Canadian jurisdiction. Accid Anal Prev. 2018;121:14\u20139. https:\/\/doi.org\/10.1016\/j.aap.2018.08.026.","journal-title":"Accid Anal Prev"},{"issue":"5","key":"1236_CR157","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1093\/pm\/pny150","volume":"20","author":"SC Mudumbai","year":"2019","unstructured":"Mudumbai SC, Lewis ET, Oliva EM, Chung PD, Harris B, Trafton J, et al. Overdose risk associated with opioid use upon hospital discharge in veterans health administration surgical patients. Pain Med. 2019;20(5):1020\u201331. https:\/\/doi.org\/10.1093\/pm\/pny150.","journal-title":"Pain Med."},{"issue":"5","key":"1236_CR158","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1001\/jama.2018.6933","volume":"320","author":"KS Ladha","year":"2018","unstructured":"Ladha KS, Gagne JJ, Patorno E, Huybrechts KF, Rathmell JP, Wang SV, et al. Opioid overdose after surgical discharge. JAMA. 2018;320(5):502\u20134. https:\/\/doi.org\/10.1001\/jama.2018.6933.","journal-title":"JAMA"},{"issue":"7","key":"1236_CR159","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1111\/add.13326","volume":"111","author":"R McDonald","year":"2016","unstructured":"McDonald R, Strang J. Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria. Addiction. 2016;111(7):1177\u201387. https:\/\/doi.org\/10.1111\/add.13326.","journal-title":"Addiction"}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-019-01236-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40265-019-01236-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-019-01236-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T19:46:32Z","timestamp":1606765592000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40265-019-01236-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,2]]},"references-count":159,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["1236"],"URL":"https:\/\/doi.org\/10.1007\/s40265-019-01236-4","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,2]]},"assertion":[{"value":"2 December 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No external funding was used in the preparation of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Pamela E. Macintyre receives pain management book royalties, is on the reviewer panel for <i>Australian Medicine\u2019s Handbook<\/i>, and is a member of the <i>Therapeutic Guidelines: Analgesic 7<\/i> expert group. Lindy J. Roberts and Christine A Huxtable have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}